Evolution of Pseudomonas aeruginosa Pathogenicity: From Acute to Chronic Infections
The DOI matches its Crossref record, with a small difference in title or year; 6 of the 6 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the inability to clear the bacteria is directly related to the chronicity of the infections [9,10].”
From Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms (2023) · cites this paper as [10]
In the citing paper
“P. aeruginosa is the main driver of chronic respiratory infections in CF and other respiratory diseases [10].”
From Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms (2023) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pseudomonas aeruginosa Displays Multiple Phenotypes during Development as a Biofilm
Sauer, K., Camper, A. K., Ehrlich, G. D., Costerton, J. W., & Davies, D. G. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.4.1140-1154.2002 · Cited by 1,691
Lung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients
Smith, E. E., Buckley, D. G., Wu, Z., Saenphimmachak, C., Hoffman, L. R., D’Argenio, D. A., Miller, S. I., Ramsey, B. W., Speert, D. P., Moskowitz, S. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602138103 · Cited by 1,319
Evolution of high mutation rates in experimental populations of E. coli
Sniegowski, P. D., Gerrish, P. J., & Lenski, R. E. (1997) · Nature · doi:10.1038/42701 · Cited by 879
Curran, B., Jonas, D., Grundmann, H., Pitt, T., & Dowson, C. G. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.12.5644-5649.2004 · Cited by 509
Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection
Häußler, S., Ziegler, I., Löttel, A., Götz, F. V., Rohde, M., Wehmhöhner, D., Saravanamuthu, S., Tümmler, B., & Steinmetz, I. (2003) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05069-0 · Cited by 228
Research works printed but not linked: 85
- Alonso, 1999, Environmental and clinical isolates of Pseudomonas aeruginosa show pathogenic and biodegradative properties irrespective of their origin, Environ. Microbiol., 1:, 421, 10.1046/j.1462-2920.1999.00052.x · DOI · Paper page
- Bagge, 2004, Dynamics and spatial distribution of β-lactamase expression in Pseudomonas aeruginosa biofilms, Antimicrob. Agents Chemother., 48:, 1168, 10.1128/AAC.48.4.1168-1174.2004 · DOI · Paper page
- Barbieri, 2004, Pseudomonas aeruginosa ExoS and ExoT, Rev. Physiol. Biochem. Pharmacol., 152:, 79, 10.1007/s10254-004-0031-7 · DOI · Paper page
- Blazquez, 2003, Hypermutation as a factor contributing to the acquisition of antimicrobial resistance, Clin. Infect. Dis., 37:, 1201, 10.1086/378810 · DOI · Paper page
- Boles, 2004, Self-generated diversity produces “insurance effects” in biofilm communities, Proc. Natl. Acad. Sci. USA., 101:, 16630, 10.1073/pnas.0407460101 · DOI · Paper page
- Bragonzi, 2005, Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model, J. Infect. Dis., 192:, 410, 10.1086/431516 · DOI
- Chopra, 2003, The role of mutators in the emergence of antibiotic-resistant bacteria, Drug Resist. Updates., 6:, 137, 10.1016/S1368-7646(03)00041-4 · DOI · Paper page
- Ciofu, 2005, Ocurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflamation, Antimicrob. Agents Chemother., 49:, 2276, 10.1128/AAC.49.6.2276-2282.2005 · DOI · Paper page
- Comolli, 1999, Pseudomonas aeruginosa gene products PilT and PilU are required for cytotoxicity in vitro and virulence in a mouse model of acute pneumonia, Infect. Immun., 67:, 3625, 10.1128/IAI.67.7.3625-3630.1999 · DOI · Paper page
- Costerton, 1999, Bacterial biofilms: a common cause of persistent infections, Science., 284:, 1318, 10.1126/science.284.5418.1318 · DOI · Paper page
- Cox, 1974, Selection for high mutation rates in chemostats, Genetics., 77:, 169, 10.1093/genetics/77.2.169 · DOI · Paper page
- Davies, 1998, The involvement of cell-to-cell signals in the development of a bacterial biofilm, Science., 280:, 295, 10.1126/science.280.5361.295 · DOI · Paper page
- Ernst, 1999, Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa, Science., 286:, 1561, 10.1126/science.286.5444.1561 · DOI · Paper page
- Evans, 1996, Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa, Eur. Respir. J., 9:, 1601, 10.1183/09031936.96.09081601 · DOI · Paper page
- Feldman, 1998, Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection, Infect. Immun., 66:, 43, 10.1128/IAI.66.1.43-51.1998 · DOI · Paper page
- Funchain, 2001, Amplification of mutator cells in a population as a result of horizontal transfer, J. Bacteriol., 183:, 3737, 10.1128/JB.183.12.3737-3741.2001 · doi:10.1128/jb.183.12.3737-3741.2001
- Gibson, 2003, Pathophysiology and management of pulmonary infections in cystic fibrosis, Am. J. Respir. Crit. Care Med., 168:, 918, 10.1164/rccm.200304-505SO · DOI · Paper page
- Giraud, 2001, Cost and benfits of high mutation rates: adaptive evolution of bacteria in the mouse gut, Science., 291:, 2606, 10.1126/science.1056421 · DOI · Paper page
- Goldman, 1997, Human β-defensin-1 is a salt sensitive antibiotic in lung that is inactivated in cystic fibrosis, Cell., 88:, 553, 10.1016/S0092-8674(00)81895-4 · DOI · Paper page
- Govan, 1996, Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia, Microbiol. Rev., 60:, 539, 10.1128/MMBR.60.3.539-574.1996 · doi:10.1128/mmbr.60.3.539-574.1996 · Paper page
- Gutiérrez, 2004, Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients, Antimicrob. Agents Chemother., 48:, 3573, 10.1128/AAC.48.9.3573-3575.2004 · DOI · Paper page
- Hanage, 2004, Molecular Microbiology: Diagnostic Principles and Practise
- Hancock, 1983, Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains defficient in lipopolysaccharide O side chains, Infect. Immun., 42:, 170, 10.1128/IAI.42.1.170-177.1983 · DOI · Paper page
- Hatch, 1998, Alginate lyase promotes diffusion of aminoglycosides through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa, Antimicrob. Agents Chemother., 42:, 974, 10.1128/AAC.42.4.974 · DOI · Paper page
- Häußler, 1999, Small colony variants of Pseudomonas aeruginosa in cystic fibrosis, Clin. Infect. Dis., 29:, 621, 10.1086/598644 · DOI · Paper page
- He, 2004, The broad host range pathogen Pseudomonas aeruginosa strain PA14 carries two pathogenicity islands harboring plant and animal virulence genes, Proc. Natl. Acad. Sci. USA., 101:, 2530, 10.1073/pnas.0304622101 · DOI · Paper page
- Henwood, 2001, Antimicrobial susceptibility of Pseudomonas aeruginosa: results of a UK survey and evaluation of the British society for antimicrobial chemotherapy disc susceptibility test, J. Antimicrob. Chemother., 47:, 789, 10.1093/jac/47.6.789 · doi:10.1093/jac/47.6.789
- Hill, 2000, Markers of airway inflammation in patients with stable chronic bronchitis, Am. J. Med., 109:, 288, 10.1016/S0002-9343(00)00507-6 · DOI · Paper page
- Hogardt, 2007, Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis, J. Infect. Dis., 195:, 70, 10.1086/509821 · DOI
- Imundo, 1995, Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface, Proc. Natl. Acad. Sci. USA., 92:, 3019, 10.1073/pnas.92.7.3019 · DOI · Paper page
- Kiewitz, 2000, Sequence diversity of Pseudomonas aeruginosa: impact on population structure and genome evolution, J. Bacteriol., 182:, 3125, 10.1128/JB.182.11.3125-3135.2000 · DOI · Paper page
- Kounnas, 1992, The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A, J. Biol. Chem., 267:, 12420, 10.1016/S0021-9258(18)42291-0 · DOI · Paper page
- Lau, 2004, The role of pyocyanin in Pseudomonas aeruginosa infection, Trends Mol. Med., 10:, 599, 10.1016/j.molmed.2004.10.002 · DOI · Paper page
- Leach, 1993, Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer, Cell., 75:, 1215, 10.1016/0092-8674(93)90330-S · DOI · Paper page
- LeClerc, 1996, High mutation frequencies among Escherichia coli and Salmonella pathogens, Science., 274:, 1208, 10.1126/science.274.5290.1208 · DOI · Paper page
- Lieberman, 2003, Pseudomonal infections in patients with COPD: epidemiology and management, Am.J. Respir. Med., 2:, 459, 10.1007/BF03256673 · DOI
- Livermore, 2002, Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?, Clin. Infect. Dis., 34:, 634, 10.1086/338782 · DOI · Paper page
- Lujan, 2007, Quorom-sensing-deficient (lasR) mutants emerge at high frequency from a Pseudomonas aeruginosa mutS strain, Microbiology., 153:, 225, 10.1099/mic.0.29021-0 · DOI · Paper page
- Lynch, 2001, Hospital-acquired pneumonia: risk factors, microbiology, and treatment, Chest., 119, 373, 10.1378/chest.119.2_suppl.373S · DOI · Paper page
- Macia, 2005, Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections, Antimicrob. Agents Chemother., 49:, 3382, 10.1128/AAC.49.8.3382-3386.2005 · DOI · Paper page
- Macia, 2004, Detection and susceptibility testing of hypermutable Pseudomonas aeruginosa strains with the Etest and disk diffusion, Antimicrob. Agents Chemother., 48:, 2665, 10.1128/AAC.48.7.2665-2672.2004 · DOI
- Maciá, 2006, Efficacy and potential for resistance selection of anti-pseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa, Antimicrob. Agents Chemother., 50:, 975, 10.1128/AAC.50.3.975-983.2006 · DOI
- Mah, 2001, Mechanisms of biofilm resistance to antimicrobial agents, Trends Microbiol., 9:, 34, 10.1016/S0966-842X(00)01913-2 · DOI · Paper page
- Mahenthiralingam, 1994, Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis, Infect. Immun., 62:, 596, 10.1128/IAI.62.2.596-605.1994 · DOI · Paper page
- Mao, 1997, Proliferation of mutators in a cell population, J. Bacteriol., 179:, 417, 10.1128/JB.179.2.417-422.1997 · DOI · Paper page
- Mariencheck, 2003, Pseudomonas aeruginosa elastase degrades surfactant proteins A and D, Am. J. Respir. Cell Mol. Biol., 28:, 528, 10.1165/rcmb.2002-0141OC · DOI · Paper page
- Matic, 1997, High variable mutation rates in commensal and pathogenic Escherichia coli, Science., 277:, 1833, 10.1126/science.277.5333.1833 · DOI · Paper page
- Matic, 1995, Interspecies gene exchange in bacteria: the role of SOS and mismatch repair systems in evolution of species, Cell., 80:, 507, 10.1016/0092-8674(95)90501-4 · DOI · Paper page
- Mena, 2007, Inactivation of the mismatch repair system in Pseudomonas aeruginosa attenuates virulence but favors persistence of oropharyngeal colonization in cystic fibrosis mice, J. Bacteriol, 189:, 3665, 10.1128/JB.00120-07 · DOI
- Meyer, 1996, Pyoverdin is essential for virulence of Pseudomonas aeruginosa, Infect. Immun., 64:, 518, 10.1128/IAI.64.2.518-523.1996 · DOI · Paper page
- Miller, 1996, Spontaneous mutators in bacteria: insights into pathways of mutagenesis and repair, Annu. Rev. Microbiol., 50:, 625, 10.1146/annurev.micro.50.1.625 · DOI · Paper page
- Montanari, 2007, Biological cost of hypermutation in Pseudomonas aeruginosa strains from patients with cystic fibrosis, Microbiology., 153:, 1445, 10.1099/mic.0.2006/003400-0 · DOI · Paper page
- Moyano, 2007, MutS deficiency and activity of the error-prone DNA polymerase IV are crucial for determining mucA as the main target for mucoid conversion in Pseudomonas aeruginosa, Mol. Microbiol., 64:, 547, 10.1111/j.1365-2958.2007.05675.x · DOI
- Nagaki, 1992, Role of chronic Pseudomonas aeruginosa infection in the development of bronchiectasis, Chest., 102:, 1464, 10.1378/chest.102.5.1464 · doi:10.1378/chest.102.5.1464
- Nicotra, 1995, Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort, Chest., 108:, 955, 10.1378/chest.108.4.955 · DOI · Paper page
- Oliver, 2002, The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants, Mol. Microbiol., 43:, 1641, 10.1046/j.1365-2958.2002.02855.x · DOI · Paper page
- Oliver, 2000, High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection, Science., 288:, 1251, 10.1126/science.288.5469.1251 · DOI · Paper page
- Oliver, 2004, Hypermutation and the pre-existence of antibiotic resistance Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections, Antimicrob. Agents Chemother., 48:, 4226, 10.1128/AAC.48.11.4226-4233.2004 · DOI
- Oliver, 1985, The effect of Pseudomonas aeruginosa alginate on rat alveolar macrophage phagocytosis and bacterial opsonization, Clin. Exp. Immunol., 59:, 190
- Parad, 1999, Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype, Infect. Immun., 67:, 4744, 10.1128/IAI.67.9.4744-4750.1999 · DOI
- Pedersen, 1990, Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflamatory response, Infect. Immun., 58:, 3363, 10.1128/IAI.58.10.3363-3368.1990 · DOI · Paper page
- Pier, 1996, Role of mutant CFTR in hypersusceptibility of cystic fibrosis to lung infections, Science., 271:, 64, 10.1126/science.271.5245.64 · DOI · Paper page
- Pirnay, 2002, Pseudomonas aeruginosa displays an epidemic population structure, Environ. Microbiol., 4:, 898, 10.1046/j.1462-2920.2002.00321.x · DOI
- Prunier, 2003, High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains, J. Infect. Dis., 187:, 1709, 10.1086/374937 · DOI · Paper page
- Rainey, 1998, Adaptive radiation in a heterogeneous environment, Nature., 394:, 69, 10.1038/27900 · DOI · Paper page
- Román, 2004, Dynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains, J. Clin. Microbiol., 42:, 1450, 10.1128/JCM.42.4.1450-1459.2004 · DOI
- Romling, 1994a, Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis, J. Infect. Dis., 170:, 1616, 10.1093/infdis/170.6.1616 · DOI · Paper page
- Römling, 1994b, A major Pseudomonas aeruginosa clone common to patients and aquatic habitats, Appl. Environ. Microbiol., 60:, 1734, 10.1128/AEM.60.6.1734-1738.1994 · DOI · Paper page
- Salyers, 2002, Pseudomonas aeruginosa and related species, a lesson of versatility,, 247
- Sato, 2004, ExoU is a potent intracellular phospholipase, Mol. Microbiol., 53:, 1279, 10.1111/j.1365-2958.2004.04194.x · DOI · Paper page
- Silo-Suh, 2005, Adaptations of Pseudomonas aeruginosa to the cystic fibrosis lung environment can include deregulation of zwf, encoding glucose-6-phosphate dehydrogenase, J. Bacteriol., 187:, 7561, 10.1128/JB.187.22.7561-7568.2005 · doi:10.1128/jb.187.22.7561-7568.2005
- Simpson, 1989, Scavenging by alginate of free radicals released by macrophages, Free Radic. Biol. Med., 6:, 347, 10.1016/0891-5849(89)90078-6 · DOI · Paper page
- Smania, 2004, Emergence of phenotypic variants upon mismatch repair disruption in Pseudomonas aeruginosa, Microbiology., 150:, 1327, 10.1099/mic.0.26751-0 · DOI
- Spencer, 2003, Whole-genome sequence variation among multiple isolates of Pseudomonas aeruginosa, J. Bacteriol., 185:, 1316, 10.1128/JB.185.4.1316-1325.2003 · DOI · Paper page
- Stover, 2000, Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen, Nature., 406:, 959, 10.1038/35023079 · DOI · Paper page
- Taddei, 1997, Role of mutator alleles in adaptive evolution, Nature., 387:, 700, 10.1038/42696 · DOI · Paper page
- Taylor, 1993a, Adult cystic fibrosis: association of acute pulmonary exacerbations and increasing severity of lung disease with auxotrophic mutants of Pseudomonas aeruginosa, Thorax., 48:, 1002, 10.1136/thx.48.10.1002 · doi:10.1136/thx.48.10.1002
- Taylor, 1993b, Auxotrophic mutants of Pseudomonas aeruginosa: increased resistance to antipseudomonal antibiotics in cystic fibrosis, Med. Microbiol. Lett., 2:, 25
- Ventre, 2006, Multiple sensors control reciprocal expression of Pseudomonas aeruginosa regulatory RNA and virulence genes, Proc. Natl. Acad. Sci. USA., 103:, 171, 10.1073/pnas.0507407103 · DOI · Paper page
- Vincent, 2003, Nosocomial infections in adult intensive-care units, Lancet., 361:, 2068, 10.1016/S0140-6736(03)13644-6 · DOI · Paper page
- Whiteley, 2001, Gene expression in Pseudomonas aeruginosa biofilms, Nature., 413:, 860, 10.1038/35101627 · DOI · Paper page
- Wilson, 1997, Effect of sputum bacteriology on the quality of life of patients with bronchiectasis, Eur. Respir. J., 10:, 1754, 10.1183/09031936.97.10081754 · DOI · Paper page
- Yahr, 1998, ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system, Proc. Natl. Acad. Sci. USA., 95:, 13899, 10.1073/pnas.95.23.13899 · DOI · Paper page
- Yoon, 2002, Pseudomonas aeruginosa anaerobic respiration in biofilms, Dev. Cell., 3:, 593, 10.1016/S1534-5807(02)00295-2 · DOI · Paper page
- Yu, 1998, Microbial pathogenesis in cystic fibrosis: pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge, Infect. Immun., 66:, 280, 10.1128/IAI.66.1.280-288.1998 · DOI
Cited by
The increasing threat of Pseudomonas aeruginosa high-risk clones
Oliver, A., Mulet, X., López-Causapé, C., & Juan, C. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.08.002 · Cited by 644
Self-citationMena, A., Smith, E. E., Burns, J. L., Speert, D. P., Moskowitz, S. M., Perez, J. L., & Oliver, A. (2008) · Journal of Bacteriology · doi:10.1128/jb.01147-08 · Cited by 251
Self-citationMechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms
Fernández-Billón, M., Llambías-Cabot, A. E., Jordana-Lluch, E., Oliver, A., & Macià, M. D. (2023) · Biofilm · doi:10.1016/j.bioflm.2023.100129 · Cited by 170
Self-citation(2024) · doi:10.1128/mbio.02395-24 · Cited by 12
Metadata
- Authors
- Oliver, A., Mena, A., & Maciá, M. D.
- Affiliations
- Servicio de Microbiología; Hospital Son Dureta; Palma de Mallorca Spain
- Venue
- Evolutionary Biology of Bacterial and Fungal Pathogens
- Publisher
- ASM Press
- Published
- 2014-04-30
- Pages
- 433-444
- Cited by
- 8
- References
- 6
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evolution of Pseudomonas aeruginosa Pathogenicity: From Acute to Chronic Infections. https://app.cochat.ai/papers/10.1128/9781555815639.ch36
- The paper
- Oliver, A., Mena, A., & Maciá, M. D. (2014). Evolution of Pseudomonas aeruginosa Pathogenicity: From Acute to Chronic Infections. Evolutionary Biology of Bacterial and Fungal Pathogens. https://doi.org/10.1128/9781555815639.ch36
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.